Form 4: Jazz Pharmaceuticals Director Receives Stock Grant
Insider Transaction (Form 4)
Heather Ann Mcsharry, a Director of Jazz Pharmaceuticals plc, received 1,605 shares of common stock on August 5, 2026.
Summary
- Grant/award: acquired 1,605 Ordinary Shares on August 5, 2026; holds 20,054 after (Direct).
Sentiment
Score: 5
Explanation: StockSavvy.ai views this as routine: the reported changes are grants, option exercises, tax withholding or similar administrative transactions, which carry limited directional signal.
Insider Transactions
Heather Ann Mcsharry — Director
| Date | Transaction | Security | Shares | Price | Value | Held After |
|---|---|---|---|---|---|---|
| 2026-08-05 | Grant/award | Ordinary Shares | 1,605 | — | — | 20,054 |
Key Dates
| Date | Description |
|---|---|
| 2026-08-05 | Grant/award (1,605 shares) |
Keywords
insider transaction, Form 4, JAZZ, Jazz Pharmaceuticals plc, neutral, Heather Ann Mcsharry
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.